Orion Biotechnology is discovering and developing G Protein-Coupled Receptor (GPCR) targeted therapeutics for the treatment of cancer and other serious diseases
Orion’s novel drug modality involves precision engineering ligands of small protein GPCRs, providing an enhanced solution to targeting previously-undrugged GPCRs. This approach is supported by one of the fastest drug discovery platforms in the industry and represents a large opportunity to discover and develop a new generation of GPCR-targeted medicines
Orion’s lead compound, OB-002, is a GPCR analog of CCL5 with best-in-class potency and a proven mechanism of action shown to have broad applicability across a range of serious diseases, including Cancer, Infectious Disease and Neuroinflammatory disorders.
Recognized
Leadership
Please join Anatole Klepatsky at the LSX World Congress (Biotech Leaders) in London, UK on May 3-4, to find out more about the exciting progress that we are making developing
The 23rd edition of BioEquity Europe is planned to begin May 14th in Dublin Ireland, and Orion Biotechnology will be there. Bio€quity Europe is the industry’s premier CEO and investor
Ottawa, Canada, Feb. 16, 2023 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs),
Ottawa, Canada, Feb. 02, 2023 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs),
Ottawa, Canada, Dec. 01, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs),
343 Preston Street
11th floor,
Ottawa, On K1S 1N4
CANADA
+1 343.291.1032
Campus Biotech
Innovation Park
Avenue de Sécheron 15
1202 Genève
SWITZERLAND
Orion Biotechnology
Life Science Park
UI Bobrzyńskiego 14
30-348 Krakôw
POLAND
Leave us a message and we will try to respond by the next business day
343 Preston Street
11th floor,
Ottawa, ON K1S 1N4
CANADA
info@orionbiotechnology.com
+1 343.291.1032
This website uses cookies to ensure you get the best experience on our site. By using this website, you agree to our use of cookies.
Leave us a message and we will try to respond by the next business day
343 Preston Street
11th floor,
Ottawa, ON K1S 1N4
CANADA
info@orionbiotechnology.com
+1 343.291.1032
